Furthermore, we have determined that autocrine hGH stimulated invasive and CSC-like properties in HCC are mediated through STAT3-dependent inhibition of CLAUDIN-1 expression and identified CLAUDIN-1 as a novel STAT3-repressed downstream target in HCC cells. The gene discussed is STAT3; the disease is hepatocellular carcinoma.